Video Experimental Relacionado
Updated: Jul 26, 2026
08:02
Manufacturing Devices and Instruments for Easier Rat Liver Transplantation
Published on: May 5, 2013
La ingeniería de pares ortogonales de ligandos y receptores de "drogas cercanas"
D F Doyle1, D A Braasch, L K Jackson
1School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332-0400, USA.
Journal of the American Chemical Society
|November 15, 2001
Resumen
Los científicos diseñaron receptores de hormonas nucleares para crear nuevas herramientas para controlar los procesos celulares. Esto implicó el desarrollo de pares ortogonales de ligando-receptor utilizando receptores mutados y compuestos inactivos similares a fármacos.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- La bioquímica es la bioquímica.
- Descubrimiento de Drogas Descubrimiento de Drogas
Sus antecedentes:
- Las moléculas pequeñas permeables a las células son esenciales para el estudio de las vías celulares.
- Los receptores de hormonas nucleares (RNH) regulan la transcripción de los genes.
- El control de NHRs específicos con moléculas externas es un desafío.
Objetivo del estudio:
- Para diseñar pares ortogonales de ligandos y receptores utilizando NHRs.
- Para demostrar la utilidad de los NHR mutados y los análogos de fármacos inactivos.
- Crear nuevas herramientas para la biología experimental y la terapia génica.
Principales métodos:
- Análisis estructural de los dominios de unión de ligando del receptor de retinoide X (RXR) y del receptor de ácido retinoico (RAR).
- Mutagénesis dirigida al sitio de RXR para crear receptores variantes.
- Cribado de "fármacos cercanos" (análogos de fármacos inactivos) para la activación de los receptores variantes.
Principales resultados:
- Diseñó un par ortogonal de ligando-receptor utilizando una variante RXR mutada (Q275C; I310M; F313I).
- El receptor de la variante fue activado por una "droga cercana" específica inactiva en el receptor de tipo salvaje.
- Demostró que los compuestos inactivos pueden ser reutilizados con proteínas mutantes.
Conclusiones:
- Los NHR son adecuados para crear pares ortogonales de ligando-receptor.
- Este enfoque proporciona nuevas herramientas para la biología experimental, la biotecnología y la terapia génica.
- Los compuestos inactivos del descubrimiento de fármacos se pueden combinar con proteínas mutantes para controlar los procesos celulares.
Videos de Conceptos Relacionados
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:23Drug Absorption Mechanism: Passive Membrane Transport
Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either weak...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...